Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke

Stroke

Volumn 40, Issue 5, 2009, Pages 1780-1785

  Hallevi, Hen ^a   Barreto, Andrew D ^a   Liebeskind, David S ^c   Morales, Miriam M ^b   Martin Schild, Sheryl B ^d   Abraham, Anitha T ^a   Gadia, Jignesh ^c   Saver, Jeffrey L ^c   Grotta, James C ^a   Savitz, Sean I ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TULANE UNIVERSITY   (United States)

Author keywords

Acute care; Acute stroke; Interventional neuroradiology; Thrombolysis

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART DISEASE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; RECANALIZATION; STROKE; TREATMENT OUTCOME; ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COHORT ANALYSIS; FEMALE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; REPRODUCIBILITY; RISK FACTOR; ROC CURVE; STATISTICAL MODEL;

ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; STROKE; TREATMENT OUTCOME;

EID: 65549105394     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.535146     Document Type: Article

References (22)

1. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. PROlyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
2. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle cerebral artery Embolism Local fibrinolytic intervention Trial (MELT) Japan. Stroke. 2007;38:2633-2639.
3. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A, Branca V, Sit SP. The penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol. 2008;29: 1409-1413.
4. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36: 1432-1438.
5. The Interventional Management of Stroke (IMS) II study. Stroke. 2007; 38:2127-2135.
6. Broderick JP, Tomsick TA. Interventional Management of Stroke (IMS) III trial. Available at: clinicaltrials.gov; Trial ID NCT00359424. Last accessed on August 1, 2008.
7. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
8. Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34: e109-e137.
9. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
10. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol. 2006;27:1177-1182.
11. Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS III, Cacayorin ED, Grotta JC, Noser EA. Is intra-ar-terial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke. 2007;38:80-84.
12. Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke. 2002;33:2866-2871.
13. Mandava P, Kent TA. Intra-arterial therapies for acute ischemic stroke. Neurology. 2007;68:2132-2139.
14. Wechsler LR, Roberts R, Furlan AJ, Higashida RT, Dillon W, Roberts H, Rowley HA, Pettigrew LC, Callahan AS III, Bruno A, Fayad P, Smith WS, Firszt CM, Schulz GA. Factors influencing outcome and treatment effect in PROACT II. Stroke. 2003;34:1224-1229.
15. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003;34:1925-1931.
16. Kim D, Ford GA, Kidwell CS, Starkman S, Vinuela F, Duckwiler GR, Jahan R, Saver JL. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol. 2007;28:159-163.
17. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Ringleb AP, Lorenzano S, Manelfe C, Bozzao L. Hemor-rhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30: 2280-2284.
18. Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, Song JK, Grotta JC, Campbell MS III. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke. 2005;36:292-296.
19. Shaltoni HM, Sugg RM, Gonzales NR, Choi JY, Cacayorin ED, Weir RU, Alexandrov AV, Malkoff MD, Grotta JC. TIMI flow grade 2b or higher predicts better outcome after intraarterial thrombolysis. Presented at the International Stroke Conference, February 2005, New Orleans, LA. 20. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612-2618.
20. Marik PE. Management of the critically ill geriatric patient. Crit Care Med. 2006;34:S176-S182.
21. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R, Santamarina E, Rubiera M. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke. 2004;35:2493-2498.
22. Kidwell CS. MR and REcanalization ofStroke Clots Using Embolectomy (MR RESCUE). Available at: clinicaltrials.gov; NCT00389467. Last accessed on August 1, 2008.